Displaying drugs 3051 - 3075 of 3120 in total
Etretinate
Etretinate is a medication used to treat severe psoriasis. It is a synthetic aromatic retinoid. The mechanism of action of etretinate is still incompletely understood although, like retinoic acid, it is thought to interfere with the terminal differentiation of keratinocytes. It is thought to bind to the retinoic acid receptors....
Withdrawn
Reidispongiolide A
Experimental
Monastrol
Experimental
CHROMOPHORE (ASP-TYR-GLY)
Experimental
Atrasentan
Atrasentan is a substance that is being studied in the treatment of cancer. It belongs to the family of drugs called endothelin-1 protein receptor antagonists. It is a novel, selective endothelin A receptor antagonist (SERA).
Investigational
BMS-275183
BMS-275183 has been used in trials studying the treatment of Tumors and Non-small Cell Lung Cancer.
Investigational
Razupenem
Razupenem has been used in trials studying the treatment of Skin Infections.
Investigational
Flurithromycin
Experimental
Cannabinor
Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational
Lanatoside C
Experimental
Sphinxolide B
Experimental
Uridine-Diphosphate-N-Acetylgalactosamine
Experimental
Uridine-Diphosphate-N-Acetylglucosamine
Experimental
D-Eritadenine
Experimental
Nelivaptan
Nelivaptan has been used in trials studying the treatment of Anxiety Disorders, Depressive Disorder, and Major Depressive Disorder.
Investigational
JTK-853
JTK-853 has been used in trials studying the treatment of Hepatitis C Virus Infection, Response to Therapy of.
Investigational
Cymarin
Experimental
Paclitaxel docosahexaenoic acid
A combination of docosahexaenoic Acid (a natural fatty acid) and paclitaxel (an anticancer drug) being studied in the treatment of cancer. It is a type of mitotic inhibitor.
Investigational
Displaying drugs 3051 - 3075 of 3120 in total